A Study of BPR-6023021 in Advanced Solid Tumors With Bone Metastases
Clinical trial NCT07249892 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07249892
- Sponsor
- Chengdu Syncor Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-19
- Primary completion
- 2027-07-30
- Enrollment
- 195
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.